Dr. Joseph Pidala, MD, PhD
Claim this profileMoffitt Cancer Center
Area of expertise
Cancer
Joseph Pidala, MD, PhD has run 4 trials for Cancer. Some of their research focus areas include:
Acute Myelogenous Leukemia
Joseph Pidala, MD, PhD has run 3 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Moffitt Cancer Center
H. Lee Moffitt Cancer Center
Clinical Trials Joseph Pidala, MD, PhD is currently running
Predicting Treatment Response
for GVHD
This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.
Recruiting
1 award
N/A
4 criteria
Ruxolitinib vs Prednisone
for Graft-versus-Host Disease
Allogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has failed 1-2 prior lines of therapy based on a prior large, randomized phase III study. Given this evidence of safety and efficacy in the early refractory setting (after prednisone failure), Ruxolitinib represents an ideal agent to test in the primary therapy setting. Here investigators propose a phase 2 randomized study to compare Ruxolitinib to prednisone as a first-line therapy in the treatment of chronic GVHD.
Recruiting
1 award
Phase 2
3 criteria
More about Joseph Pidala, MD, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Joseph Pidala, MD, PhD has experience with
- Quality-of-Life Assessment
- Medical Chart Review
- Biospecimen Collection
- Donor Search Prognosis Score
- Placebo
- Abatacept
Breakdown of trials Joseph Pidala, MD, PhD has run
Cancer
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph Pidala, MD, PhD specialize in?
Joseph Pidala, MD, PhD focuses on Cancer and Acute Myelogenous Leukemia. In particular, much of their work with Cancer has involved T315I positive patients, or patients who are Stage I.
Is Joseph Pidala, MD, PhD currently recruiting for clinical trials?
Yes, Joseph Pidala, MD, PhD is currently recruiting for 3 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Joseph Pidala, MD, PhD has studied deeply?
Yes, Joseph Pidala, MD, PhD has studied treatments such as Quality-of-Life Assessment, Medical Chart Review, Biospecimen Collection.
What is the best way to schedule an appointment with Joseph Pidala, MD, PhD?
Apply for one of the trials that Joseph Pidala, MD, PhD is conducting.
What is the office address of Joseph Pidala, MD, PhD?
The office of Joseph Pidala, MD, PhD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.